'All of Us Are in for a Long Haul': NewPort Beach's OnSite Waste Gears Up to Help Free Hospitals of Hazardous Waste

Francesca Billington

Francesca Billington is a freelance reporter. Prior to that, she was a general assignment reporter for dot.LA and has also reported for KCRW, the Santa Monica Daily Press and local publications in New Jersey. She graduated from Princeton in 2019 with a degree in anthropology.

'All of Us Are in for a Long Haul': NewPort Beach's OnSite Waste Gears Up to Help Free Hospitals of Hazardous Waste

As the country prepares for mass COVID-19 vaccinations, OnSite Waste Technologies is expecting a spike in demand.

The Newport Beach-based company's device quickly sterilizes needles and other biomedical waste, a process that can take clinics and nursing homes over a month as they ship off the hazardous materials to one of the country's several dozen incinerators.

The company saw demand jump as the pandemic left nursing homes and assisted living facilities with piles of waste. Their orders rose 500% between May and July compared to the same quarter last year.

"Waste was storing up in those facilities and they weren't letting the hauling services come in," said Brad Barnes, the startup's co-founder and CEO.

Armed with a $3.5 million Series A round led by Mark IV Capital, the company is readying to ramp up production of their printer-sized device. It sterilizes biomedical waste products like personal protective gear by heating them up to 400 degrees for 90 minutes. The process gets rid of all viruses like COVID-19, bacteria and other spores, allowing the the old products to be disposed of in a trash can.

The company, which launched last year, currently rents its hardware to long-term care facilities and clinics for infusion therapy and male testosterone replacement in 41 states. Barnes said it took a total of three years to receive regulatory approval, which varies for each state.

Offices can run about 200 needles through the sterilization machine during each three-hour cycle. After the machine heats this so-called "red-bag" waste and lets it cool, it's safe enough to throw away with normal trash.

Barnes said switching to his technology can save businesses up to 60% in costs compared to paying for the traditional method of medical waste disposal. It also reduces a company's risk to exposing healthcare workers to infectious diseases.

"If nothing else, it shortens their liability time," he said.

In the last four months the startup has grown its team by 40%, Barnes said, and they're looking to increase it by another 40. The latest round bumps the startup's total funding to $8.5 million.

With roughly 40 million people living in California alone, Barnes is eying opportunity. He sees mobile vaccination units, for example, as potential customers across the country.

"What we see ahead of us is 10 billion new injections that were never expected or planned that'll take place in the next couple of years," he said. "All of us are in for a long haul."

California's acting state public health officer said earlier this week that, while a number of doses might be available by the end of the year, widespread vaccination probably won't be ready for "many more months."

**This story has been updated.


Subscribe to our newsletter to catch every headline.

LA Venture: B Capital’s Howard Morgan on What To Look For in Potential Founders

Decerry Donato

Decerry Donato is a reporter at dot.LA. Prior to that, she was an editorial fellow at the company. Decerry received her bachelor's degree in literary journalism from the University of California, Irvine. She continues to write stories to inform the community about issues or events that take place in the L.A. area. On the weekends, she can be found hiking in the Angeles National forest or sifting through racks at your local thrift store.

LA Venture: B Capital’s Howard Morgan on What To Look For in Potential Founders
Provided by LAV

On this episode of the LA Venture podcast, B Capital Group General Partner and Chair Howard Morgan discusses his thoughts on early stage investing and the importance of company ownership.

Read moreShow less

Mullen Automotive Pays Millions to Settle Lawsuit with Qiantu

David Shultz

David Shultz reports on clean technology and electric vehicles, among other industries, for dot.LA. His writing has appeared in The Atlantic, Outside, Nautilus and many other publications.

Mullen Automotive Pays Millions to Settle Lawsuit with Qiantu
Image Courtesy of Mullen Automotive

Like a zombie from the grave, Mullen Automotive’s electric sports car grift lives once more. Earlier this week, the Southern Californian company announced that it had resolved its contract disputes with Chinese manufacturer Qiantu and would begin to “re-design” and “re-engineer” the DragonFLY K50 platform for sale in the United States.

On the surface (or if you just read the press release) this would seem to be excellent news for the Californian EV startup. But the saga of the Mullen/Qiantu partnership is long, and in the context of their shared history, the deal’s terms look considerably less favorable for Mullen.

Read moreShow less